Skip to main content
Clinical Trials/IRCT20200721048159N6
IRCT20200721048159N6
Not yet recruiting
Phase 3

Evaluation of the Effects of Vitamins E, C and D Separately and Synergistically on Pain and Anxiety Score Caused by Withdrawal Syndrome in Patients Who are Candidate for Withdrawal: A Randomized Controlled Clinical Trial

Khoram-Abad University of Medical Sciences0 sites125 target enrollmentTBD

Overview

Phase
Phase 3
Intervention
Not specified
Conditions
Anxiety and pain caused by drug withdrawal in addicted patients.
Sponsor
Khoram-Abad University of Medical Sciences
Enrollment
125
Status
Not yet recruiting
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
2 years ago
Study Type
Interventional
Sex
Male

Investigators

Sponsor
Khoram-Abad University of Medical Sciences

Eligibility Criteria

Inclusion Criteria

  • Confirmed diagnosis of opioids and stimulants substances
  • Men over 18 years old
  • The emergence of withdrawal syndrome based on the diagnosis of a psychiatrist
  • a score of at least 3 in the VAS test
  • Performing a TLC test to detect consumption (methadone, morphine, amphetamine and etc..)
  • Consent to participating in the study

Exclusion Criteria

  • Taking multivitamin, mineral and antioxidant supplements in the last 3 months before starting the intervention
  • Liver or kidney failure

Outcomes

Primary Outcomes

Not specified

Similar Trials